$CDIO News
Last published 2mo ago
- 2mo agoCDIOCardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access ChallengesBusiness WireThe report reflects the current state of rural cardiovascular care in America and offers an exclusive roadmap for rural health organizations navigating ongoing workforce shortages and access challenges.Cardio
- 2mo agoCDIOCardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa CityBusiness WireThe new in-house laboratory facility will give Cardio Diagnostics end-to-end ownership of test processing and expand research capabilities for ongoing and future studies in precision monitoring of cardiovascular
- 3mo agoCDIOCardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026Business WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) ("Cardio Diagnostics" or the "Company"), a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the
- 4mo agoCDIOAtlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its NetworkBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas Healthcare Physicians (AHP), a community-driven, independent physician association (IPA)
- 5mo agoCDIOCardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in JuneBusiness WireThese evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an
- 5mo agoCDIOIBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc.GlobeNewswireAUSTIN, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the
- 7mo agoCDIOIBN Initiates Coverage of Cardio Diagnostics Holdings Inc.GlobeNewswireAUSTIN, Texas, April 08, 2026 (GLOBE NEWSWIRE) -- via IBN -- Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for
- 8mo agoCDIOCardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026Business WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) ("Cardio Diagnostics" or the "Company"), a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the prevention and
- 10mo agoCDIOCardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota CommunityBusiness WireSouthdale YMCA, part of YMCA of the North, becomes the second YMCA location nationally to partner with Cardio Diagnostics, expanding community access to AI-powered cardiovascular testing and education Cardio
- 11mo agoCDIOCardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)Business WireThe final gapfill payment rate for both the Epi+Gen CHD™ and PrecisionCHD™ tests is higher at $854 compared to the preliminary gapfill payment rates of $350 for Epi+Gen CHD™ and $684.76 for
- 1y agoCDIOCardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD's Ability to Detect INOCA and MINOCA at the American Heart Association Scientific SessionsBusiness WireIschemia with No Obstructive Coronary Arteries (INOCA) and Myocardial Infarction with No Obstructive Coronary Arteries (MINOCA) are two underdiagnosed, potentially fatal forms of heart disease that standard diagnostic
- 1y agoCDIOCardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee CommunityBusiness WireA customized program for YMCA of East Tennessee members will include educational series "Wisdom Wednesdays," and access to Cardio Diagnostics' AI-powered cardiovascular testing at discounted rates from home or during
- 1y agoCDIOCardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United StatesBusiness WireGrowing Adoption of AI-Driven Precision Cardiovascular Medicine Tests Spans Concierge, Functional Medicine, and Primary Care Practices Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven Precision
- 1y agoCDIOCardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)Business WireObtaining the payment rates marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, today
- 1y agoCDIOCardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart DiseaseBusiness WireAGEPHA Pharma will supply LODOCO® (low-dose colchicine) for a Cardio Diagnostics-sponsored clinical study to explore the use of Cardio Diagnostics' PrecisionCHD™ test to identify patients with
- 1y agoCDIOCardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection TechnologyBusiness WireCardio Diagnostics Holdings Inc. (NASDAQ:CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office has issued a patent for another set of
- 1y agoCDIOCardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid PriceBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) ("Cardio Diagnostics" or the "Company"), a pioneer in AI-powered precision cardiovascular medicine, today announced that on May 28, 2025, it received a notification letter
- 1y agoCDIOCardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto RicoBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), a pioneer in AI-powered precision cardiovascular medicine, today announced the continued expansion of its reach with a new cohort of healthcare practices across the
- 1y agoCDIOCardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock SplitBusiness WireCardio Diagnostics Holdings, Inc. ("Cardio" or the "Company") (NASDAQ:CDIO), today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025. The reverse stock split
- 1y agoCDIOCardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific SessionBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, today announced its participation in the American College of Cardiology's 74th Annual Scientific Session &
- 1y agoCDIOCardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider OrganizationsBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven Precision Cardiovascular Medicine company, today announced that the Company has partnered with seven new provider organizations. This expansion highlights
- 1y agoBIAFCDIOINBSSOBR+1Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029GlobeNewswirePALM BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Due to the expanding consumption of illicit drugs & alcohol across the globe the Drug Screening market is poised to grow
- 1y agoCDIOCardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular TestsBusiness WireCMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision cardiovascular medicine company today
- 1y agoCDIOCardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual ConferenceBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, today announced it will sponsor and exhibit at the Florida Association of ACOs (FLAACOs) 2024 Annual Fall
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular TestsBusiness WirePreliminary CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision cardiovascular medicine company
- 2y agoCDIOCardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular SolutionsBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its redesigned website at CDIO.AI. This new site emphasizes the Company's
- 2y agoCDIOCardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, IllinoisBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company's clinical blood test, Epi+Gen CHD is now available at Family Medicine
- 2y agoCDIOCardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics ForumBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company will sponsor a booth and showcase its groundbreaking cardiovascular solutions at
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and ConfidentialityBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), a leader in AI-driven precision cardiovascular medicine, today announced the successful completion of its System and Organization Controls (SOC) 2 Type I audit, achieving
- 2y agoCDIOCardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative TestsBusiness WireCompany to recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the Molecular Diagnostic Services (MolDx) program. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a WeekBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company's clinical blood tests, Epi+Gen CHD and PrecisionCHD, are now available at Family
- 2y agoCDIOCardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million AnnuallyBusiness WireThe Peer-Reviewed Publication Demonstrates the Potential Economic Benefits of the PrecisionCHD™ Test for the Detection and Management of Coronary Heart Disease, which is One of the Largest Cost Centers for Public
- 2y agoCDIOExponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in MichiganBusiness WireExponential Health, an innovative concierge medicine practice in Michigan, adopts Cardio Diagnostics' AI-driven epigenetic-genetic tests, marking a new era in personalized and preventive cardiac care. In a
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with NavierreBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision cardiovascular medicine company, announces a strategic partnership with Navierre, an innovative digital health technology platform which
- 2y agoCDIOCardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology's 73rd Annual Scientific SessionBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, announces that the Company will showcase its groundbreaking HeartRiskTM and Actionable Clinical IntelligenceTM
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular DiseaseBusiness WireCompany Continues to Build and Expand the Global IP Portfolio of Its One-of-a-Kind Technology Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision cardiovascular medicine company, announces that the
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide RolloutBusiness WireTransformative Cardiovascular Risk Management Solutions Extend Beyond Traditional Sectors to Include Federal and State Correctional Facilities, Broker and Benefits Organizations, and Risk Bearing Providers. Cardio
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart SupercentersBusiness WireAgreement is the first introduction of AI-driven epigenetic heart attack risk assessment and coronary heart disease detection tests in a retail healthcare setting on a walk-in basis. Cardio Diagnostics Holdings, Inc.
- 2y agoCDIOHouston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease TestsBusiness WireresTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular disease tests Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic AdvisorBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision cardiovascular medicine company, today announced the appointment of Dr. Vimal Ramjee, MD FACC CCMS, as a Strategic Advisor. Dr. Ramjee is a
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in IndiaBusiness WireThe Company's global patent portfolio includes granted patents in the United States, Europe, India, Australia, China and Hong Kong, and numerous pending patents worldwide Cardio Diagnostics Holdings, Inc.
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™Business WireHeartRisk™ Empowers Employers Who Adopt Cardio Diagnostics' Solutions to Proactively Combat Cardiovascular Disease in Their Workforce and Mitigate Business Risks Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO),
- 2y agoCDIOAmerican Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease EventBusiness WireThis is the second CPT PLA code the American Medical Association (AMA) granted for the Company's AI-powered coronary heart disease tests. This significant milestone enables the acceleration of reimbursement for the
- 2y agoCDIOAmerican Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.'s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement CodeBusiness WireObtaining a CPT PLA code marks a key milestone in securing reimbursement from federal and private payers for, and expanding access to the innovative PrecisionCHD test powered by AI and epigenetics Cardio Diagnostics
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of DirectorsBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven precision cardiovascular medicine company, today announced the appointment of Paul Burton, J.D., MBA to its Board of Directors as an Independent Director.
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price RequirementBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) ("Cardio Diagnostics" or the "Company"), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced that on December 5, 2023, it
- 2y agoCDIOCardio Diagnostics Holdings, Inc's Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness WireThe roundtable will bring together healthcare stakeholders to discuss operationalizing value-based care with novel risk-stratification strategies in the cardiovascular disease space Cardio Diagnostics Holdings, Inc.
- 2y agoCDIOAmerican Medical Association is Reviewing Cardio Diagnostics Holdings, Inc's Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA CodesBusiness WireCPT codes are critical to receiving reimbursement from federal and private payers Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests,
- 2y agoCDIOCardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart AssociationBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced the publication of its groundbreaking study in the Journal of the
- 3y agoCDIOFamily Medicine Specialists Selects Cardio Diagnostics' Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield PatientsBusiness WireCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, and Family Medicine Specialists (FMS), a leading Illinois primary care provider with